BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

402 related articles for article (PubMed ID: 21925292)

  • 1. Cysteine Cathepsins in the secretory vesicle produce active peptides: Cathepsin L generates peptide neurotransmitters and cathepsin B produces beta-amyloid of Alzheimer's disease.
    Hook V; Funkelstein L; Wegrzyn J; Bark S; Kindy M; Hook G
    Biochim Biophys Acta; 2012 Jan; 1824(1):89-104. PubMed ID: 21925292
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Unique neuronal functions of cathepsin L and cathepsin B in secretory vesicles: biosynthesis of peptides in neurotransmission and neurodegenerative disease.
    Hook VY
    Biol Chem; 2006; 387(10-11):1429-39. PubMed ID: 17081116
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cathepsin L in secretory vesicles functions as a prohormone-processing enzyme for production of the enkephalin peptide neurotransmitter.
    Yasothornsrikul S; Greenbaum D; Medzihradszky KF; Toneff T; Bundey R; Miller R; Schilling B; Petermann I; Dehnert J; Logvinova A; Goldsmith P; Neveu JM; Lane WS; Gibson B; Reinheckel T; Peters C; Bogyo M; Hook V
    Proc Natl Acad Sci U S A; 2003 Aug; 100(16):9590-5. PubMed ID: 12869695
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lysosomal processing of amyloid precursor protein to A beta peptides: a distinct role for cathepsin S.
    Munger JS; Haass C; Lemere CA; Shi GP; Wong WS; Teplow DB; Selkoe DJ; Chapman HA
    Biochem J; 1995 Oct; 311 ( Pt 1)(Pt 1):299-305. PubMed ID: 7575468
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of cathepsin B reduces beta-amyloid production in regulated secretory vesicles of neuronal chromaffin cells: evidence for cathepsin B as a candidate beta-secretase of Alzheimer's disease.
    Hook V; Toneff T; Bogyo M; Greenbaum D; Medzihradszky KF; Neveu J; Lane W; Hook G; Reisine T
    Biol Chem; 2005 Sep; 386(9):931-40. PubMed ID: 16164418
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cathepsin L expression is directed to secretory vesicles for enkephalin neuropeptide biosynthesis and secretion.
    Hwang SR; Garza C; Mosier C; Toneff T; Wunderlich E; Goldsmith P; Hook V
    J Biol Chem; 2007 Mar; 282(13):9556-9563. PubMed ID: 17244622
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Beta-amyloid peptide in regulated secretory vesicles of chromaffin cells: evidence for multiple cysteine proteolytic activities in distinct pathways for beta-secretase activity in chromaffin vesicles.
    Hook VY; Toneff T; Aaron W; Yasothornsrikul S; Bundey R; Reisine T
    J Neurochem; 2002 Apr; 81(2):237-56. PubMed ID: 12064471
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Unique biological function of cathepsin L in secretory vesicles for biosynthesis of neuropeptides.
    Funkelstein L; Beinfeld M; Minokadeh A; Zadina J; Hook V
    Neuropeptides; 2010 Dec; 44(6):457-66. PubMed ID: 21047684
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The novel role of cathepsin L for neuropeptide production illustrated by research strategies in chemical biology with protease gene knockout and expression.
    Funkelstein L; Hook V
    Methods Mol Biol; 2011; 768():107-25. PubMed ID: 21805239
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cathepsin L participates in the production of neuropeptide Y in secretory vesicles, demonstrated by protease gene knockout and expression.
    Funkelstein L; Toneff T; Hwang SR; Reinheckel T; Peters C; Hook V
    J Neurochem; 2008 Jul; 106(1):384-91. PubMed ID: 18410501
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cysteine protease inhibitors reduce brain beta-amyloid and beta-secretase activity in vivo and are potential Alzheimer's disease therapeutics.
    Hook G; Hook VY; Kindy M
    Biol Chem; 2007 Sep; 388(9):979-83. PubMed ID: 17696783
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Secretory vesicle aminopeptidase B related to neuropeptide processing: molecular identification and subcellular localization to enkephalin- and NPY-containing chromaffin granules.
    Hwang SR; O'Neill A; Bark S; Foulon T; Hook V
    J Neurochem; 2007 Mar; 100(5):1340-50. PubMed ID: 17241125
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cathepsins S, B and L with aminopeptidases display β-secretase activity associated with the pathogenesis of Alzheimer's disease.
    Schechter I; Ziv E
    Biol Chem; 2011 Apr; 392(6):555-69. PubMed ID: 21585286
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cysteine cathepsins: from structure, function and regulation to new frontiers.
    Turk V; Stoka V; Vasiljeva O; Renko M; Sun T; Turk B; Turk D
    Biochim Biophys Acta; 2012 Jan; 1824(1):68-88. PubMed ID: 22024571
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Loss of Cathepsin B and L Leads to Lysosomal Dysfunction, NPC-Like Cholesterol Sequestration and Accumulation of the Key Alzheimer's Proteins.
    Cermak S; Kosicek M; Mladenovic-Djordjevic A; Smiljanic K; Kanazir S; Hecimovic S
    PLoS One; 2016; 11(11):e0167428. PubMed ID: 27902765
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cysteine peptidases of Eudiplozoon nipponicum: a broad repertoire of structurally assorted cathepsins L in contrast to the scarcity of cathepsins B in an invasive species of haematophagous monogenean of common carp.
    Jedličková L; Dvořáková H; Dvořák J; Kašný M; Ulrychová L; Vorel J; Žárský V; Mikeš L
    Parasit Vectors; 2018 Mar; 11(1):142. PubMed ID: 29510760
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A possible role for cathepsins D, E, and B in the processing of beta-amyloid precursor protein in Alzheimer's disease.
    Mackay EA; Ehrhard A; Moniatte M; Guenet C; Tardif C; Tarnus C; Sorokine O; Heintzelmann B; Nay C; Remy JM; Higaki J; Van Dorsselaer A; Wagner J; Danzin C; Mamont P
    Eur J Biochem; 1997 Mar; 244(2):414-25. PubMed ID: 9119007
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of cathepsin B as a mediator of neuronal death induced by Abeta-activated microglial cells using a functional genomics approach.
    Gan L; Ye S; Chu A; Anton K; Yi S; Vincent VA; von Schack D; Chin D; Murray J; Lohr S; Patthy L; Gonzalez-Zulueta M; Nikolich K; Urfer R
    J Biol Chem; 2004 Feb; 279(7):5565-72. PubMed ID: 14612454
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The cysteine protease inhibitor, E64d, reduces brain amyloid-β and improves memory deficits in Alzheimer's disease animal models by inhibiting cathepsin B, but not BACE1, β-secretase activity.
    Hook G; Hook V; Kindy M
    J Alzheimers Dis; 2011; 26(2):387-408. PubMed ID: 21613740
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Proteomic identification of protease cleavage sites characterizes prime and non-prime specificity of cysteine cathepsins B, L, and S.
    Biniossek ML; Nägler DK; Becker-Pauly C; Schilling O
    J Proteome Res; 2011 Dec; 10(12):5363-73. PubMed ID: 21967108
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.